Skip to main content

Macrogenics Inc

MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001125345

In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Macrogenics Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of MGNX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders135137+2
Shares56.7M58.4M+1.74M (+3.1%)
Value$380.5M$419.1M+$38.6M (+10.1%)

New holders (20)

Institutions that held Macrogenics Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to MGNX in Q1 2023
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.1,703,204$12.2M0.88%
Marshall Wace, LLP257,948$1.85M0.00%
Ikarian Capital, LLC250,000$1.79M0.74%
Alpha DNA Investment Management LLC156,937$1.13M0.58%
Victory Capital Management Inc133,750$959.0K0.00%
AE Wealth Management LLC83,156$596.2K0.00%
Corton Capital Inc.75,326$540.1K0.37%
Delphia (USA) Inc.61,047$437.7K0.54%
Boothbay Fund Management, LLC50,175$359.8K0.01%
Group One Trading, L.P.32,318$231.7K0.01%
Virtu Financial LLC23,116$166.0K0.02%
Bayesian Capital Management, LP21,632$155.1K0.02%
Raymond James Financial Services Advisors, Inc.18,383$131.8K0.00%
Dynamic Technology Lab Private Ltd10,200$73.0K0.01%
Zurcher Kantonalbank (Zurich Cantonalbank)3,789$27.2K0.00%
Macroview Investment Management LLC1,674$12.0K0.02%
Dark Forest Capital Management LP1,370$9.82K0.00%
Point72 Asset Management, L.P.540$3.87K0.00%
Lindbrook Capital, LLC378$2.71K0.00%
EverSource Wealth Advisors, LLC10$720.00%

Sold out (18)

Institutions that held Macrogenics Inc at the end of Q4 2022 and filed for Q1 2023 without it.